SCOPE 2023

by Feb 15, 2023

SCOPE Summit 2023:

Driving Innovation in Clinical Trials and Digital Health

The Nurocor team is pleased to have participated in SCOPE 2023 (Orlando, Florida). It was great to see so many people in person again, and to meet with customers, partners, and prospective customers. Traffic at our booth was exceptional. Thank you for stopping by. We appreciated the in-depth discussions and demonstrations.

Nurocor also chaired a panel session entitled: Clinical Development: The Future of Pharmaceutical Drug Development. The session focused on the benefits of digitalized clinical development from three different perspectives: pharmaceutical company, CRO, and Nurocor as a technology vendor with an advanced clinical platform.

The panel session included presentations from:

Mike Sullivan

(Executive Director, BMS)

Barrie Nelson

(Executive Vice President, Nurocor)

Gregg Dearhammer

(Senior Vice President, IQVIA)

We look forward to seeing you at SCOPE 2024.